[HTML][HTML] N-acetylcysteine treats intravenous amiodarone induced liver injury
ML Mudalel, KP Dave, JP Hummel… - World Journal of …, 2015 - ncbi.nlm.nih.gov
We report a case of intravenous (IV) amiodarone drug induced liver injury (DILI). The patient
received IV N-acetylcysteine (NAC) which resulted in a rapid improvement in liver enzymes …
received IV N-acetylcysteine (NAC) which resulted in a rapid improvement in liver enzymes …
Amiodarone-induced severe hepatitis mediated by immunological mechanisms.
HW Breuer, W Bossek, C Haferland… - … journal of clinical …, 1998 - europepmc.org
A 64-year-old man developed a fulminant hepatitis 4 days after initiation of amiodarone
treatment and a total dose of 7.1 g. The direct Coombs test was positive and became …
treatment and a total dose of 7.1 g. The direct Coombs test was positive and became …
Acute amiodarone-induced hepatitis.
N Kalantzis, P Gabriel, J Mouzas, D Tiniakos… - Hepato …, 1991 - europepmc.org
Two fatal cases of amiodarone-induced acute, confluent, necrotic hepatitis are described.
The patients, aged 28 and 60, had received a high loading dose of amiodarone. After the …
The patients, aged 28 and 60, had received a high loading dose of amiodarone. After the …
Acute amiodarone liver toxicity likely due to ischemic hepatitis.
N Gluck, M Fried, R Porat - Sat, 2011 - ima.org.il
Background: Hepatotoxicity due to intravenous amiodarone (HIVAD) is a rare side effect with
a distinct pattern of enzyme disturbances compared to liver damage from oral amiodarone …
a distinct pattern of enzyme disturbances compared to liver damage from oral amiodarone …
[PDF][PDF] The evolving spectrum of amiodarone hepatotoxicity
B Rigas - Hepatology, 1989 - Wiley Online Library
The evolving spectrum of amiodarone hepatotoxicity Page 1 HEPATOLOGY 116 HEPATOLOGY
ELSEWHERE timately involved in fluid, electrolyte, and blood-pressure homeostasis. N Engl …
ELSEWHERE timately involved in fluid, electrolyte, and blood-pressure homeostasis. N Engl …
Drug-induced steatohepatitis
V Patel, AJ Sanyal - Clinics in liver disease, 2013 - liver.theclinics.com
Hepatic steatosis is defined as fat deposition within hepatocytes (Fig. 1). It is seen
microscopically as vacuoles in a microvesicular or macrovesicular distribution …
microscopically as vacuoles in a microvesicular or macrovesicular distribution …
Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes
A Berson, V De Beco, P Lettéron, MA Robin, C Moreau… - Gastroenterology, 1998 - Elsevier
Background & Aims: 4, 4'-Diethylaminoethoxyhexestrol (DEAEH), amiodarone, and
perhexiline cause steatohepatitis in humans. The mechanisms of these effects are unknown …
perhexiline cause steatohepatitis in humans. The mechanisms of these effects are unknown …
The low incidence of primary liver disease in patients with nonalcoholic steatohepatitis
M Basaranoglu, A Sonsuz, H Senturk… - Journal of …, 2001 - journal-of-hepatology.eu
The low incidence of primary liver disease in patients with nonalcoholic steatohepatitis
sinophilia in our case suggests an allergic reaction. Druginduced immunoallergic hepatitis is …
sinophilia in our case suggests an allergic reaction. Druginduced immunoallergic hepatitis is …
Acute hepatitis induced by parenteral amiodarone
SA Gregory, JB Webster, GD Chapman - The American journal of …, 2002 - amjmed.com
Hepatic dysfunction, most commonly an elevation of aminotransferases, develops in 15% to
40% of patients receiving amiodarone (1). However, acute hepatitis induced by parenteral …
40% of patients receiving amiodarone (1). However, acute hepatitis induced by parenteral …
[PDF][PDF] Fatty liver and drugs
Drug-induced liver diseases (DILD) are clinico-pathologic patterns of liver injury caused by
drugs or other foreign compounds. Steatohepatitis is a rare form of DILD, and drugs account …
drugs or other foreign compounds. Steatohepatitis is a rare form of DILD, and drugs account …